InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
1
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the complete record of transactions filed by Hagen Heidi, 董事. Officer active across 2 companies, notably Vericel Corp. In total, 10 disclosures have been recorded. Breakdown: 1 buy · 0 sell. Total volume traded: €35k. Activity tracked since 19 May 2021. The latest transaction was filed on 23 March 2026 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Hagen Heidi
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报10 总计
3,200 股Common StockSEC:0001140361-26-018543:0
15,000 股@ US$2.7640.1% 占其流量Common StockSEC:0001140361-26-011091:0
3,200 股Common StockSEC:0001140361-25-017118:0
9,000 股@ US$3.7453.1% 占其流量Common StockSEC:0001140361-25-007181:0
4,000 股@ US$3.7422.7% 占其流量Common StockSEC:0001140361-24-043798:0
3,200 股Common StockSEC:0001140361-24-024331:0
2,600 股Common StockSEC:0001140361-23-021498:0
2,600 股Common StockSEC:0001593968-22-000888:0
23,770 股@ US$1.76100.0% 占其流量Common StockSEC:0001209191-21-054829:0
标准退出：2021年12月1日 (T+90)
1,500 股@ US$6.008.3% 占其流量Common StockSEC:0001593968-21-001389:0
10 条申报中的 10 条
About Hagen Heidi
Heidi Hagen is a Board Member at Vericel Corp and ZIOPHARM ONCOLOGY INC. She plays an important role in the governance of these companies, bringing her expertise in strategy and management. As a board member, she participates in strategic decision-making and guides the companies toward a sustainable future.
